Structural Insight into the Complex Formation of Latent Matrix Metalloproteinase 2 with Tissue Inhibitor of Metalloproteinase 2

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2002 May 29

PMID 12032297

Citations 74

Authors

Ekaterina Morgunova

Ari Tuuttila

Ulrich Bergmann

Karl Tryggvason

Affiliations

Soon will be listed here.

Abstract

Matrix metalloproteinases (MMPs) are a family of multidomain enzymes involved in the physiological degradation of connective tissue, as well as in pathological states such as tumor invasion and arthritis. Apart from transcriptional regulation, MMPs are controlled by proenzyme activation and a class of specific tissue inhibitors of metalloproteinases (TIMPs) that bind to the catalytic site. TIMP-2 is a potent inhibitor of MMPs, but it has also been implicated in a unique cell surface activation mechanism of latent MMP-2/gelatinase A/type IV collagenase (proMMP-2), through its binding to the hemopexin domain of proMMP-2 on the one hand and to a membrane-type MMP activator on the other. The present crystal structure of the human proMMP-2/TIMP-2 complex reveals an interaction between the hemopexin domain of proMMP-2 and the C-terminal domain of TIMP-2, leaving the catalytic site of MMP-2 and the inhibitory site of TIMP-2 distant and spatially isolated. The interfacial contact of these two proteins is characterized by two distinct binding regions composed of alternating hydrophobic and hydrophilic interactions. This unique structure provides information for how specificity for noninhibitory MMP/TIMP complex formation is achieved.

Citing Articles

Metalloproteases and their inhibitors in the postpartum endometrial remodeling in dairy cows: their relationship with days to conception after parturition.

Grotter L, Cainelli S, Peralta M, Angeli E, Belotti E, Ortega H Vet Res Commun. 2024; 49(1):53.

PMID: 39714564 DOI: 10.1007/s11259-024-10622-7.

A clinical and molecular characterization of a Pakistani family with multicentric osteolysis, nodulosis and arthropathy (MONA) syndrome.

Ahmad S, Muurinen M, Loid P, Ali M, Muzammal M, Fatima S Bone Rep. 2024; 22:101789.

PMID: 39540058 PMC: 11558256. DOI: 10.1016/j.bonr.2024.101789.

The Role of Biomarkers in Predicting Outcomes of Anterior Cruciate Ligament Reconstruction: A Systematic Review.

Batty L, Mackenzie C, Landwehr C, Webster K, Feller J Orthop J Sports Med. 2024; 12(10):23259671241275072.

PMID: 39380669 PMC: 11460236. DOI: 10.1177/23259671241275072.

Mapping Extracellular Protein-Protein Interactions Using Extracellular Proximity Labeling (ePL).

Peeney D, Gurung S, Rich J, Coates-Park S, Liu Y, Toor J J Proteome Res. 2024; 23(10):4715-4728.

PMID: 39238192 PMC: 11460327. DOI: 10.1021/acs.jproteome.4c00606.

Matrix Metalloproteinases in the Periodontium-Vital in Tissue Turnover and Unfortunate in Periodontitis.

Radzki D, Negri A, Kusiak A, Obuchowski M Int J Mol Sci. 2024; 25(5).

PMID: 38474009 PMC: 10932118. DOI: 10.3390/ijms25052763.

References

Butler G, Apte S, Willenbrock F, Murphy G . Human tissue inhibitor of metalloproteinases 3 interacts with both the N- and C-terminal domains of gelatinases A and B. Regulation by polyanions. J Biol Chem. 1999; 274(16):10846-51. DOI: 10.1074/jbc.274.16.10846. View

Morgunova E, Tuuttila A, Bergmann U, Isupov M, Lindqvist Y, Schneider G . Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed. Science. 1999; 284(5420):1667-70. DOI: 10.1126/science.284.5420.1667. View

Nagase H, Woessner Jr J . Matrix metalloproteinases. J Biol Chem. 1999; 274(31):21491-4. DOI: 10.1074/jbc.274.31.21491. View

Paoli M, Anderson B, BAKER H, Morgan W, Smith A, Baker E . Crystal structure of hemopexin reveals a novel high-affinity heme site formed between two beta-propeller domains. Nat Struct Biol. 1999; 6(10):926-31. DOI: 10.1038/13294. View

ter Haar E, Harrison S, Kirchhausen T . Peptide-in-groove interactions link target proteins to the beta-propeller of clathrin. Proc Natl Acad Sci U S A. 2000; 97(3):1096-100. PMC: 15533. DOI: 10.1073/pnas.97.3.1096. View

Overall C, Tam E, McQuibban G, Morrison C, Wallon U, Bigg H . Domain interactions in the gelatinase A.TIMP-2.MT1-MMP activation complex. The ectodomain of the 44-kDa form of membrane type-1 matrix metalloproteinase does not modulate gelatinase A activation. J Biol Chem. 2000; 275(50):39497-506. DOI: 10.1074/jbc.M005932200. View

Winn M, Isupov M, Murshudov G . Use of TLS parameters to model anisotropic displacements in macromolecular refinement. Acta Crystallogr D Biol Crystallogr. 2001; 57(Pt 1):122-33. DOI: 10.1107/s0907444900014736. View

Murphy G, Willenbrock F, WARD R, Cockett M, Eaton D, Docherty A . The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases. Biochem J. 1992; 283 ( Pt 3):637-41. PMC: 1130931. DOI: 10.1042/bj2830637. View

Merritt E, Murphy M . Raster3D Version 2.0. A program for photorealistic molecular graphics. Acta Crystallogr D Biol Crystallogr. 1994; 50(Pt 6):869-73. DOI: 10.1107/S0907444994006396. View

10.

Kolkenbrock H, Orgel D, NOACK W, Ulbrich N . The complex between a tissue inhibitor of metalloproteinases (TIMP-2) and 72-kDa progelatinase is a metalloproteinase inhibitor. Eur J Biochem. 1991; 198(3):775-81. DOI: 10.1111/j.1432-1033.1991.tb16080.x. View

11.

Howard E, Banda M . Binding of tissue inhibitor of metalloproteinases 2 to two distinct sites on human 72-kDa gelatinase. Identification of a stabilization site. J Biol Chem. 1991; 266(27):17972-7. View

12.

Nicholls A, Sharp K, Honig B . Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins. 1991; 11(4):281-96. DOI: 10.1002/prot.340110407. View

13.

Jones T, Zou J, Cowan S, Kjeldgaard M . Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A. 1991; 47 ( Pt 2):110-9. DOI: 10.1107/s0108767390010224. View

14.

Wilhelm S, Collier I, Marmer B, Eisen A, Grant G, Goldberg G . SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem. 1989; 264(29):17213-21. View

15.

Otwinowski Z, Minor W . Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 1997; 276:307-26. DOI: 10.1016/S0076-6879(97)76066-X. View

16.

Stetler-Stevenson W, Krutzsch H, Liotta L . Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. J Biol Chem. 1989; 264(29):17374-8. View

17.

Kolkenbrock H, Orgel D, Zimmermann J, Ulbrich N . Generation and activity of the ternary gelatinase B/TIMP-1/LMW-stromelysin-1 complex. Biol Chem Hoppe Seyler. 1995; 376(8):495-500. DOI: 10.1515/bchm3.1995.376.8.495. View

18.

Libson A, Gittis A, Collier I, Marmer B, Goldberg G, Lattman E . Crystal structure of the haemopexin-like C-terminal domain of gelatinase A. Nat Struct Biol. 1995; 2(11):938-42. DOI: 10.1038/nsb1195-938. View

19.

Gooley P, OConnell J, Marcy A, Cuca G, Salowe S, Bush B . The NMR structure of the inhibited catalytic domain of human stromelysin-1. Nat Struct Biol. 1994; 1(2):111-8. DOI: 10.1038/nsb0294-111. View

20.

Browner M, Smith W, Castelhano A . Matrilysin-inhibitor complexes: common themes among metalloproteases. Biochemistry. 1995; 34(20):6602-10. DOI: 10.1021/bi00020a004. View